Team led by Andrew West joins global network to unravel the complexity of Parkinson’s disease
A research team led by Andrew West, PhD, professor of pharmacology and cancer biology at Duke, has been selected to join the Collaborative Research Network, an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease, through a $9 million grant awarded by Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research.
Haystead receives inaugural Neil L. Spector, MD, Legacy Award for Transformational Lyme and Tick-Borne Disease Research
Timothy Haystead, PhD, professor of pharmacology and cancer biology, has been honored with the inaugural Neil L. Spector, MD, Legacy Award for Transformational Lyme and Tick-Borne Disease Research, from the Bay Area Lyme Foundation. The award is the foundation’s highest scientific honor, recognizing bold, rigorous, translational research that moves patients closer to answers.
Hawgood and Prochazka awarded Lung Cancer Initiative fellowships
Bryony Hawgood, a Cell and Molecular Biology PhD student in the lab of Trudy Oliver, PhD, and Patrick Prochazka, a Molecular Cancer Biology PhD student in the lab of Christopher Counter, PhD, have Lung Cancer Initiative fellowships effective July 1, 2026. These one-year fellowships provide stipends to students across North and South Carolina "who wish to pursue a career in lung cancer research, diagnosis, treatment and/or care."
